DiscGenics, Inc. products

DiscGenics uses its patented allogeneic cell culture manufacturing technology to isolate cells from donated adult human intervertebral disc tissue and induce a progenitor state. These proprietary Discogenic Cells are then expanded for therapeutic application, combined with a delivery vehicle and cryopreserved for off-the-shelf use.

DiscGenics is harnessing the restorative potential of cells native to the intervertebral disc to develop what we believe will be a profound therapeutic option for millions of patients suffering from the debilitating effects of low back pain.